Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
I am 43 year female and get 1st dose of vaccine yesterday; fever; nausea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a 43-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 01-AUG-2025, the patient received the 1st dose of Shingles vaccine. On 01-AUG-2025, an unknown time after receiving Shingles vaccine, the patient experienced inappropriate age at vaccine administration (Verbatim: I am 43 year female and get 1st dose of vaccine yesterday). In AUG-2025, the patient experienced fever (Verbatim: fever) and nausea (Verbatim: nausea). The outcome of the fever and nausea were not resolved and the outcome of the inappropriate age at vaccine administration was not applicable. It was unknown if the reporter considered the fever and nausea to be related to Shingles vaccine. It was unknown if the company considered the fever and nausea to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 02-AUG-2025 This case was reported by the patient via interactive digital media. The patient received 1st dose of vaccine yesterday (day before reporting) and now (on the time of reporting) she had fever and nausea. Less than a week, after received Shingles vaccine, the patient experienced fever and nausea. The patient received 1st dose of Shingles vaccine earlier than the recommended age, which led to an inappropriate age at vaccine administration.